Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease -: Results from a German national survey

被引:87
|
作者
Langhorst, J
Anthonisen, IB
Steder-Neukamm, U
Lüdtke, R
Spahn, G
Michalsen, A
Dobos, GJ
机构
[1] Kliniken Essen Mitte, Dept Internal Med, D-45276 Essen, Germany
[2] Univ Duisburg Essen, Dept Gastroenterol & Hepatol, Duisburg, Germany
[3] German Crohns & Ulcerat Colitis Assoc, Leverkusen, Germany
[4] Karl & Veronica Carstens Fdn, Essen, Germany
关键词
alternative medicine; complementary medicine; Crohn's disease; ulcerative colitis;
D O I
10.1097/01.MIB.0000160771.71328.6c
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Previous studies have suggested that inflammatory bowel disease (IBD) patients rank high among users of complementary and alternative medicine (CAM). To further elucidate this phenomenon, we sent questionnaires to a large sample of IBD patients in Germany to determine the patterns and predictors of their CAM use. Methods: Pretested 73-item questionnaires were mailed to a randomly selected representative sample of 1000 1 BD patients from the approximately 16,000 members and associates of the German Crohn's and Colitis Association. Predictors of CAM use were evaluated by logistic regression models. Results: Completed questionnaires were returned by 684 patients (female patients, 61.4%; Crohn's disease patients, 58.3%; ulcerative colitis patients, 38.2%). Of the 671 adult respondents, 344 (51.3%) had experience with CAM, and significantly more of the ulcerative colitis patients (59.8%) than the Crohn's disease patients (48.3%) had experience with CAM. There was no difference by gender. Homeopathy (52.9%) and herbal medicine (43.6%) were the most commonly used types of CAM. The most frequent personal reasons for CAM use were the search for an "optimum treatment" (78.9%) and the wish to stop taking steroids (63.8%). Using logistic regression, we found that total cortisone intake (P = 0.0077), but not duration of disease, was a strong predictor of CAM use. Other predictors were experience with psychosomatic and psychotherapeutic support (P = 0.0029), relaxation techniques (P = 0.0284), an academic education (P = 0.0173), a diet utilizing whole grains (P = 0.0123), and a normal body weight (P = 0.0215). Although 80% of patients indicated that they were interested in using CAM in the future, only 24.7% felt sufficiently informed about it. Conclusions: More than 50% of a large group of German IBD patients had used CAM. Prolonged or intensive steroid treatment, an academic education, active ways of coping, and a health-conscious life-style are associated with CAM use. Given the potential side effects and interactions, the treating physician should focus on thorough information about the benefits and limitations of conventional and complementary treatment options, especially for IBD patients who have received prolonged or intensive steroid treatment.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 50 条
  • [1] Use of Complementary and Alternative Medicine by Greek Patients with Inflammatory Bowel Disease
    Triantafillidis, John K.
    Gikas, Aristofanis
    Kontrarou, Georgia
    Konstantoulakis, Manousos
    Papalois, Apostolos
    NUTRIENTS, 2024, 16 (21)
  • [2] Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey
    Hilsden, RJ
    Meddings, JB
    Verhoef, MJ
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1999, 13 (04): : 327 - 332
  • [3] Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey
    Abitbol, Vered
    Lahmek, Pierre
    Buisson, Anne
    Olympie, Alain
    Poupardin, Cecile
    Chaussade, Stanislas
    Lesgourgues, Bruno
    Nahon, Stephane
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (03) : 288 - 294
  • [4] Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002
    Bauer, Nina
    Kairey, Lana
    Schlee, Christoph
    Uecker, Christine
    Oeznur, Oezlem
    Langhorst, Jost
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (10) : 1209 - 1215
  • [5] Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases
    Almakadma, Abdul Hakim
    De Vol, Abdelkarim
    Alabdaljabar, Mohamad S.
    Aldosari, Sarah
    Muhsen, Ibrahim
    AlFreihi, Omar
    Kurdi, Amr
    Almadi, Majid
    Alsohaibani, Fahad
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2023, 29 (04) : 233 - 239
  • [6] Use of Complementary Medicine in Pediatric Patients With Inflammatory Bowel Disease: Results From a Multicenter Survey
    Wong, Anthony P.
    Clark, Ann L.
    Garnett, Elizabeth A.
    Acree, Michael
    Cohen, Stanley A.
    Ferry, George D.
    Heyman, Melvin B.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2009, 48 (01) : 55 - 60
  • [7] Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease
    Garcia-Planella, Esther
    Marin, Laura
    Domenech, Eugeni
    Bernal, Isabel
    Manosa, Miriam
    Zabana, Yamile
    Gassull, Miquel A.
    MEDICINA CLINICA, 2007, 128 (02): : 45 - 48
  • [8] Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Disease
    Phatak, Uma P.
    Alper, Arik
    Pashankar, Dinesh S.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 68 (02) : 157 - 160
  • [9] Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway
    Opheim, Randi
    Bernklev, Tomm
    Fagermoen, May Solveig
    Cvancarova, Milada
    Moum, Bjorn
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (12) : 1436 - 1447
  • [10] Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study
    Oxelmark, Lena
    Lindberg, Annelie
    Lofberg, Robert
    Sternby, Berit
    Eriksson, Anders
    Almer, Sven
    Befrits, Ragnar
    Fossum, Bjoorn
    Karlen, Per
    Brostrom, Olle
    Tysk, Curt
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (11) : 1320 - 1328